Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001732670 | SCV001983023 | uncertain significance | not provided | 2023-01-05 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Invitae | RCV001732670 | SCV002384936 | likely benign | not provided | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001732670 | SCV003831171 | uncertain significance | not provided | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003913353 | SCV004732576 | uncertain significance | COL11A2-related disorder | 2024-01-19 | criteria provided, single submitter | clinical testing | The COL11A2 c.5087C>T variant is predicted to result in the amino acid substitution p.Thr1696Met. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.020% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |